Önal, UğurAkyol, DenizMert, MerveBaskol, DilsahMemetali, Seichan ChouseinSanlidag, GamzeKenanoglu, BuseUyan-Onal, AyseQuliyeva, GunelAvsar, Cansu BulutAkdag, DamlaDemir, MelikeErdem, Huseyin AytacKahraman, UmitBozbiyik, OsmanOzgiray, ErkinBozkurt, DevrimAkarca, Funda KarbekDemirag, KubilayCankayali, IlkinUyar, MehmetCilli, FerihaArda, BilginYamazhan, TansuPullukcu, HusnuTasbakan, Meltem IsikgozSipahi, HilalUlusoy, SercanSipahi, Oguz Resat2024-10-212024-10-212022-04-161120-009Xhttps://doi.org/10.1080/1120009X.2022.2064703https://www.tandfonline.com/doi/full/10.1080/1120009X.2022.2064703https://hdl.handle.net/11452/46760This study aimed to evaluate the influencing variables for outcomes in patients with septic shock having culture-proven carbapenem-resistant Gram-negative pathogens. It included 120 patients (mean age 64.29 +/- 1.35 years and 58.3% female). The mean Sequential Organ Failure Assessment score during septic shock diagnosis was found to be 11.22 +/- 0.43 and 9 +/- 0.79 among the patients with mortality and among the survivors, respectively (P = 0.017). The logistic regression analysis showed that empirical treatment as mono Gram-negative bacteria-oriented antibiotic therapy (P = 0.016, odds ratio (OR) = 17.730, 95% confidence interval (CI): 1.728-182.691), Charlson Comorbidity Index >2 (P = 0.032, OR = 7.312, 95% CI: 5.7-18.3), and systemic inflammatory response syndrome score 3 or 4 during septic shock diagnosis (P = 0.014, OR = 5.675, 95% CI: 1.424-22.619) were found as independent risk factors for day 30 mortality. Despite early diagnosis and effective management of patients with septic shock, the mortality rates are quite high in CRGNP-infected patients.eninfo:eu-repo/semantics/closedAccessInfectious-diseases-societyClinical-practice guidelinesManagementMortalitySepsisPneumoniaDiagnosisAdultsCarbapenem resistanceGram-negative pathogensSeptic shockOncologyInfectious diseasesPathologyPharmacology & pharmacyArticle00078449220000143644534710.1080/1120009X.2022.2064703